A small study of 156 people with COVID-19 has found that mutations that confer resistance to antiviral drugs were “commonly detected”, especially in immunocompromised patients. The authors stress that ...
On Monday, September 23, 2024, the US Food and Drug Administration announced a nationwide recall on remdesivir, which goes by the brand name Veklury. One hundred milligram (100 mg) vials of Veklury ...